Skip to main content
Erschienen in: Annals of Surgical Oncology 13/2022

26.08.2022 | Thoracic Oncology

Prediction of Individual Lymph Node Metastatic Status in Esophageal Squamous Cell Carcinoma Using Routine Computed Tomography Imaging: Comparison of Size-Based Measurements and Radiomics-Based Models

verfasst von: Chenyi Xie, MD, PhD, Yihuai Hu, MD, PhD, Lujun Han, MD, PhD, Jianhua Fu, MD, PhD, Varut Vardhanabhuti, FRCR, PhD, Hong Yang, MD, PhD

Erschienen in: Annals of Surgical Oncology | Ausgabe 13/2022

Einloggen, um Zugang zu erhalten

Abstract

Background

Lymph node status is vital for prognosis and treatment decisions for esophageal squamous cell carcinoma (ESCC). This study aimed to construct and evaluate an optimal radiomics-based method for a more accurate evaluation of individual regional lymph node status in ESCC and to compare it with traditional size-based measurements.

Methods

The study consecutively collected 3225 regional lymph nodes from 530 ESCC patients receiving upfront surgery from January 2011 to October 2015. Computed tomography (CT) scans for individual lymph nodes were analyzed. The study evaluated the predictive performance of machine-learning models trained on features extracted from two-dimensional (2D) and three-dimensional (3D) radiomics by different contouring methods. Robust and important radiomics features were selected, and classification models were further established and validated.

Results

The lymph node metastasis rate was 13.2% (427/3225). The average short-axis diameter was 6.4 mm for benign lymph nodes and 7.9 mm for metastatic lymph nodes. The division of lymph node stations into five regions according to anatomic lymph node drainage (cervical, upper mediastinal, middle mediastinal, lower mediastinal, and abdominal regions) improved the predictive performance. The 2D radiomics method showed optimal diagnostic results, with more efficient segmentation of nodal lesions. In the test set, this optimal model achieved an area under the receiver operating characteristic curve of 0.841–0.891, an accuracy of 84.2–94.7%, a sensitivity of 65.7–83.3%, and a specificity of 84.4–96.7%.

Conclusions

The 2D radiomics-based models noninvasively predicted the metastatic status of an individual lymph node in ESCC and outperformed the conventional size-based measurement. The 2D radiomics-based model could be incorporated into the current clinical workflow to enable better decision-making for treatment strategies.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman DJ. Global cancer statistics. CA A Cancer J Clin. 2011;61:69–90.CrossRef Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman DJ. Global cancer statistics. CA A Cancer J Clin. 2011;61:69–90.CrossRef
2.
Zurück zum Zitat Sugawara K, Yamashita H, Uemura Y, et al. Numeric pathologic lymph node classification shows prognostic superiority to topographic pN classification in esophageal squamous cell carcinoma. Surgery. 2017;162:846–56.PubMedCrossRef Sugawara K, Yamashita H, Uemura Y, et al. Numeric pathologic lymph node classification shows prognostic superiority to topographic pN classification in esophageal squamous cell carcinoma. Surgery. 2017;162:846–56.PubMedCrossRef
3.
Zurück zum Zitat Gabriel E, Attwood K, Du W, et al. Association between clinically staged node-negative esophageal adenocarcinoma and overall survival benefit from neoadjuvant chemoradiation. JAMA Surg. 2016;151:234–45.PubMedPubMedCentralCrossRef Gabriel E, Attwood K, Du W, et al. Association between clinically staged node-negative esophageal adenocarcinoma and overall survival benefit from neoadjuvant chemoradiation. JAMA Surg. 2016;151:234–45.PubMedPubMedCentralCrossRef
4.
Zurück zum Zitat Rice TW, Ishwaran H, Hofstetter WL, et al. Esophageal cancer: associations with (pN+) lymph node metastases. Ann Surg. 2017;265:122–9.PubMedCrossRef Rice TW, Ishwaran H, Hofstetter WL, et al. Esophageal cancer: associations with (pN+) lymph node metastases. Ann Surg. 2017;265:122–9.PubMedCrossRef
5.
Zurück zum Zitat Kutup A, Nentwich MF, Bollschweiler E, Bogoevski D, Izbicki JR, Hölscher AH. What should be the gold standard for the surgical component in the treatment of locally advanced esophageal cancer: transthoracic versus transhiatal esophagectomy. Ann Surg. 2014;260:1016–22.PubMedCrossRef Kutup A, Nentwich MF, Bollschweiler E, Bogoevski D, Izbicki JR, Hölscher AH. What should be the gold standard for the surgical component in the treatment of locally advanced esophageal cancer: transthoracic versus transhiatal esophagectomy. Ann Surg. 2014;260:1016–22.PubMedCrossRef
6.
Zurück zum Zitat Rizk NP, Ishwaran H, Rice TW, et al. Optimum lymphadenectomy for esophageal cancer. Ann Surg. 2010;251:46–50.PubMedCrossRef Rizk NP, Ishwaran H, Rice TW, et al. Optimum lymphadenectomy for esophageal cancer. Ann Surg. 2010;251:46–50.PubMedCrossRef
7.
Zurück zum Zitat D’Journo XB. Clinical implication of the innovations of the 8(th) edition of the TNM classification for esophageal and esophago-gastric cancer. J Thorac Dis. 2018;10(Suppl 22):S2671–81.PubMedPubMedCentralCrossRef D’Journo XB. Clinical implication of the innovations of the 8(th) edition of the TNM classification for esophageal and esophago-gastric cancer. J Thorac Dis. 2018;10(Suppl 22):S2671–81.PubMedPubMedCentralCrossRef
8.
Zurück zum Zitat Choi J, Kim SG, Kim JS, Jung HC, Song IS. Comparison of endoscopic ultrasonography (EUS), positron emission tomography (PET), and computed tomography (CT) in the preoperative locoregional staging of resectable esophageal cancer. Surg Endosc. 2010;24:1380–6.PubMedCrossRef Choi J, Kim SG, Kim JS, Jung HC, Song IS. Comparison of endoscopic ultrasonography (EUS), positron emission tomography (PET), and computed tomography (CT) in the preoperative locoregional staging of resectable esophageal cancer. Surg Endosc. 2010;24:1380–6.PubMedCrossRef
9.
Zurück zum Zitat Kato H, Kuwano H, Nakajima M, et al. Comparison between positron emission tomography and computed tomography in the use of the assessment of esophageal carcinoma. Cancer. 2002;94:921–8.PubMedCrossRef Kato H, Kuwano H, Nakajima M, et al. Comparison between positron emission tomography and computed tomography in the use of the assessment of esophageal carcinoma. Cancer. 2002;94:921–8.PubMedCrossRef
10.
Zurück zum Zitat Li J, Chen S, Zhu G. Comparative study of computed tomography (CT) and pathological diagnosis toward mediastinal lymph node metastasis in esophageal carcinoma. Rev Assoc Med Bras. 2018;64:170–4.PubMedCrossRef Li J, Chen S, Zhu G. Comparative study of computed tomography (CT) and pathological diagnosis toward mediastinal lymph node metastasis in esophageal carcinoma. Rev Assoc Med Bras. 2018;64:170–4.PubMedCrossRef
11.
Zurück zum Zitat Takemura M, Osugi H, Takada N, Kinoshita H, Higashino M. Prognostic factors in patients with squamous oesophageal cancer associated with solitary lymph node metastasis after oesophagectomy and extended lymphadenectomy. Oncol Rep. 2003;10:75–80.PubMed Takemura M, Osugi H, Takada N, Kinoshita H, Higashino M. Prognostic factors in patients with squamous oesophageal cancer associated with solitary lymph node metastasis after oesophagectomy and extended lymphadenectomy. Oncol Rep. 2003;10:75–80.PubMed
12.
Zurück zum Zitat Cao Q, Li Y, Li Z, An D, Li B, Lin Q. Development and validation of a radiomics signature on differentially expressed features of (18)F-FDG PET to predict treatment response of concurrent chemoradiotherapy in thoracic esophagus squamous cell carcinoma. Radiother Oncol. 2020;146:9–15.PubMedCrossRef Cao Q, Li Y, Li Z, An D, Li B, Lin Q. Development and validation of a radiomics signature on differentially expressed features of (18)F-FDG PET to predict treatment response of concurrent chemoradiotherapy in thoracic esophagus squamous cell carcinoma. Radiother Oncol. 2020;146:9–15.PubMedCrossRef
13.
Zurück zum Zitat Hu Y, Xie C, Yang H, et al. Assessment of intratumoral and peritumoral computed tomography radiomics for predicting pathological complete response to neoadjuvant chemoradiation in patients with esophageal squamous cell carcinoma. JAMA Netw Open. 2020;3:e2015927.PubMedPubMedCentralCrossRef Hu Y, Xie C, Yang H, et al. Assessment of intratumoral and peritumoral computed tomography radiomics for predicting pathological complete response to neoadjuvant chemoradiation in patients with esophageal squamous cell carcinoma. JAMA Netw Open. 2020;3:e2015927.PubMedPubMedCentralCrossRef
14.
Zurück zum Zitat Yang Z, He B, Zhuang X, et al. CT-based radiomic signatures for prediction of pathologic complete response in esophageal squamous cell carcinoma after neoadjuvant chemoradiotherapy. J Radiat Res. 2019;60:538–45.PubMedPubMedCentralCrossRef Yang Z, He B, Zhuang X, et al. CT-based radiomic signatures for prediction of pathologic complete response in esophageal squamous cell carcinoma after neoadjuvant chemoradiotherapy. J Radiat Res. 2019;60:538–45.PubMedPubMedCentralCrossRef
15.
Zurück zum Zitat Beukinga RJ, Hulshoff JB, Mul VEM, et al. Prediction of response to neoadjuvant chemotherapy and radiation therapy with baseline and restaging (18)F-FDG PET imaging biomarkers in patients with esophageal cancer. Radiology. 2018;287:983–92.PubMedCrossRef Beukinga RJ, Hulshoff JB, Mul VEM, et al. Prediction of response to neoadjuvant chemotherapy and radiation therapy with baseline and restaging (18)F-FDG PET imaging biomarkers in patients with esophageal cancer. Radiology. 2018;287:983–92.PubMedCrossRef
16.
Zurück zum Zitat Hou Z, Ren W, Li S, et al. Radiomic analysis in contrast-enhanced CT: predict treatment response to chemoradiotherapy in esophageal carcinoma. Oncotarget. 2017;8:104444–54.PubMedPubMedCentralCrossRef Hou Z, Ren W, Li S, et al. Radiomic analysis in contrast-enhanced CT: predict treatment response to chemoradiotherapy in esophageal carcinoma. Oncotarget. 2017;8:104444–54.PubMedPubMedCentralCrossRef
17.
Zurück zum Zitat Beukinga RJ, Hulshoff JB, van Dijk LV, et al. Predicting response to neoadjuvant chemoradiotherapy in esophageal cancer with textural features derived from pretreatment (18)F-FDG PET/CT imaging. J Nuclear Med. 2017;58:723–9.CrossRef Beukinga RJ, Hulshoff JB, van Dijk LV, et al. Predicting response to neoadjuvant chemoradiotherapy in esophageal cancer with textural features derived from pretreatment (18)F-FDG PET/CT imaging. J Nuclear Med. 2017;58:723–9.CrossRef
18.
Zurück zum Zitat Qiu Q, Duan J, Deng H, et al. Development and validation of a radiomics nomogram model for predicting postoperative recurrence in patients with esophageal squamous cell cancer who achieved pCR after neoadjuvant chemoradiotherapy followed by surgery. Front Oncol. 2020;10:1398.PubMedPubMedCentralCrossRef Qiu Q, Duan J, Deng H, et al. Development and validation of a radiomics nomogram model for predicting postoperative recurrence in patients with esophageal squamous cell cancer who achieved pCR after neoadjuvant chemoradiotherapy followed by surgery. Front Oncol. 2020;10:1398.PubMedPubMedCentralCrossRef
19.
Zurück zum Zitat Chen YH, Lue KH, Chu SC, et al. Combining the radiomic features and traditional parameters of (18)F-FDG PET with clinical profiles to improve prognostic stratification in patients with esophageal squamous cell carcinoma treated with neoadjuvant chemoradiotherapy and surgery. Ann Nuclear Med. 2019;33:657–70.CrossRef Chen YH, Lue KH, Chu SC, et al. Combining the radiomic features and traditional parameters of (18)F-FDG PET with clinical profiles to improve prognostic stratification in patients with esophageal squamous cell carcinoma treated with neoadjuvant chemoradiotherapy and surgery. Ann Nuclear Med. 2019;33:657–70.CrossRef
20.
Zurück zum Zitat Yang CK, Yeh JC, Yu WH, et al. Deep convolutional neural network-based positron emission tomography analysis predicts esophageal cancer outcome. J Clin Med. 2019;8:844. PubMedCentralCrossRef Yang CK, Yeh JC, Yu WH, et al. Deep convolutional neural network-based positron emission tomography analysis predicts esophageal cancer outcome. J Clin Med. 2019;8:844. PubMedCentralCrossRef
21.
Zurück zum Zitat Xie C, Yang P, Zhang X, et al. Subregion-based radiomics analysis for survival prediction in oesophageal tumours treated by definitive concurrent chemoradiotherapy. EbioMedicine. 2019;44:289–97.PubMedPubMedCentralCrossRef Xie C, Yang P, Zhang X, et al. Subregion-based radiomics analysis for survival prediction in oesophageal tumours treated by definitive concurrent chemoradiotherapy. EbioMedicine. 2019;44:289–97.PubMedPubMedCentralCrossRef
22.
Zurück zum Zitat Larue R, Klaassen R, Jochems A, et al. Pre-treatment CT radiomics to predict 3-year overall survival following chemoradiotherapy of esophageal cancer. Acta Oncol Stockholm Sweden. 2018;57:1475–81.CrossRef Larue R, Klaassen R, Jochems A, et al. Pre-treatment CT radiomics to predict 3-year overall survival following chemoradiotherapy of esophageal cancer. Acta Oncol Stockholm Sweden. 2018;57:1475–81.CrossRef
23.
Zurück zum Zitat Foley KG, Hills RK, Berthon B, et al. Development and validation of a prognostic model incorporating texture analysis derived from standardised segmentation of PET in patients with oesophageal cancer. Eur Radiol. 2018;28:428–36.PubMedCrossRef Foley KG, Hills RK, Berthon B, et al. Development and validation of a prognostic model incorporating texture analysis derived from standardised segmentation of PET in patients with oesophageal cancer. Eur Radiol. 2018;28:428–36.PubMedCrossRef
24.
Zurück zum Zitat Xiong J, Yu W, Ma J, Ren Y, Fu X, Zhao J. The role of PET-based radiomic features in predicting local control of esophageal cancer treated with concurrent chemoradiotherapy. Sci Rep. 2018;8:9902.PubMedPubMedCentralCrossRef Xiong J, Yu W, Ma J, Ren Y, Fu X, Zhao J. The role of PET-based radiomic features in predicting local control of esophageal cancer treated with concurrent chemoradiotherapy. Sci Rep. 2018;8:9902.PubMedPubMedCentralCrossRef
25.
Zurück zum Zitat Xie C-Y, Hu Y-H, Ho JW-K, et al. Using genomics feature selection method in radiomics pipeline improves prognostication performance in locally advanced esophageal squamous cell carcinoma: a pilot study. Cancers. 2021;13:2145.PubMedPubMedCentralCrossRef Xie C-Y, Hu Y-H, Ho JW-K, et al. Using genomics feature selection method in radiomics pipeline improves prognostication performance in locally advanced esophageal squamous cell carcinoma: a pilot study. Cancers. 2021;13:2145.PubMedPubMedCentralCrossRef
26.
Zurück zum Zitat Tan X, Ma Z, Yan L, Ye W, Liu Z, Liang C. Radiomics nomogram outperforms size criteria in discriminating lymph node metastasis in resectable esophageal squamous cell carcinoma. Eur Radiol. 2019;29:392–400.PubMedCrossRef Tan X, Ma Z, Yan L, Ye W, Liu Z, Liang C. Radiomics nomogram outperforms size criteria in discriminating lymph node metastasis in resectable esophageal squamous cell carcinoma. Eur Radiol. 2019;29:392–400.PubMedCrossRef
27.
Zurück zum Zitat Wu L, Yang X, Cao W, et al. Multiple level CT radiomics features preoperatively predict lymph node metastasis in esophageal cancer: a multicentre retrospective study. Front Oncol. 2019;9:1548.PubMedCrossRef Wu L, Yang X, Cao W, et al. Multiple level CT radiomics features preoperatively predict lymph node metastasis in esophageal cancer: a multicentre retrospective study. Front Oncol. 2019;9:1548.PubMedCrossRef
28.
Zurück zum Zitat Amin MB, Greene FL, Edge SB, et al. The eighth edition AJCC cancer staging manual: continuing to build a bridge from a population-based to a more “personalized” approach to cancer staging. CA Cancer J Clin. 2017;67:93–9.PubMedCrossRef Amin MB, Greene FL, Edge SB, et al. The eighth edition AJCC cancer staging manual: continuing to build a bridge from a population-based to a more “personalized” approach to cancer staging. CA Cancer J Clin. 2017;67:93–9.PubMedCrossRef
29.
Zurück zum Zitat Fluss R, Faraggi D, Reiser B. Estimation of the Youden Index and its associated cutoff point. Biometr J. 2005;47:458–72.CrossRef Fluss R, Faraggi D, Reiser B. Estimation of the Youden Index and its associated cutoff point. Biometr J. 2005;47:458–72.CrossRef
30.
Zurück zum Zitat Hatt M, Vallieres M, Visvikis D, Zwanenburg A. IBSI: an international community radiomics standardization initiative. J Nucl Med. 2018;59(1):287. Hatt M, Vallieres M, Visvikis D, Zwanenburg A. IBSI: an international community radiomics standardization initiative. J Nucl Med. 2018;59(1):287.
31.
Zurück zum Zitat DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics. 1988;44:837–45.PubMedCrossRef DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics. 1988;44:837–45.PubMedCrossRef
32.
Zurück zum Zitat Powers DM. Evaluation: from precision, recall and F-measure to ROC, informedness, markedness and correlation. arXiv preprint arXiv:2010.16061. 2020. Powers DM. Evaluation: from precision, recall and F-measure to ROC, informedness, markedness and correlation. arXiv preprint arXiv:2010.16061. 2020.
33.
Zurück zum Zitat Yu J, Ouyang W, Li C, et al. Mapping patterns of metastatic lymph nodes for postoperative radiotherapy in thoracic esophageal squamous cell carcinoma: a recommendation for clinical target volume definition. BMC cancer. 2019;19:927.PubMedPubMedCentralCrossRef Yu J, Ouyang W, Li C, et al. Mapping patterns of metastatic lymph nodes for postoperative radiotherapy in thoracic esophageal squamous cell carcinoma: a recommendation for clinical target volume definition. BMC cancer. 2019;19:927.PubMedPubMedCentralCrossRef
34.
Zurück zum Zitat Ortiz-Ramon R, Larroza A, Arana E, Moratal D. A radiomics evaluation of 2D and 3D MRI texture features to classify brain metastases from lung cancer and melanoma. Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference. 2017. p. 493–6. Ortiz-Ramon R, Larroza A, Arana E, Moratal D. A radiomics evaluation of 2D and 3D MRI texture features to classify brain metastases from lung cancer and melanoma. Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference. 2017. p. 493–6.
35.
Zurück zum Zitat Shen C, Liu Z, Guan M, et al. 2D and 3D CT radiomics features prognostic performance comparison in non-small cell lung cancer. Translat Oncol. 2017;10:886–94.CrossRef Shen C, Liu Z, Guan M, et al. 2D and 3D CT radiomics features prognostic performance comparison in non-small cell lung cancer. Translat Oncol. 2017;10:886–94.CrossRef
36.
Zurück zum Zitat Yang L, Yang J, Zhou X, et al. Development of a radiomics nomogram based on the 2D and 3D CT features to predict the survival of non-small cell lung cancer patients. Eur Radiol. 2019;29:2196–206.PubMedCrossRef Yang L, Yang J, Zhou X, et al. Development of a radiomics nomogram based on the 2D and 3D CT features to predict the survival of non-small cell lung cancer patients. Eur Radiol. 2019;29:2196–206.PubMedCrossRef
37.
Zurück zum Zitat Lubner MG, Stabo N, Lubner SJ, et al. CT textural analysis of hepatic metastatic colorectal cancer: pre-treatment tumor heterogeneity correlates with pathology and clinical outcomes. Abdom Imaging. 2015;40:2331–7.PubMedCrossRef Lubner MG, Stabo N, Lubner SJ, et al. CT textural analysis of hepatic metastatic colorectal cancer: pre-treatment tumor heterogeneity correlates with pathology and clinical outcomes. Abdom Imaging. 2015;40:2331–7.PubMedCrossRef
38.
Zurück zum Zitat Daly JM, Karnell LH, Menck HR. National Cancer Data Base report on esophageal carcinoma. Cancer. 1996;78:1820–8.PubMedCrossRef Daly JM, Karnell LH, Menck HR. National Cancer Data Base report on esophageal carcinoma. Cancer. 1996;78:1820–8.PubMedCrossRef
39.
Zurück zum Zitat Ng T, Vezeridis MP. Advances in the surgical treatment of esophageal cancer. J Surg Oncol. 2010;101:725–9.PubMedCrossRef Ng T, Vezeridis MP. Advances in the surgical treatment of esophageal cancer. J Surg Oncol. 2010;101:725–9.PubMedCrossRef
40.
Zurück zum Zitat Pasquali S, Yim G, Vohra RS, et al. Survival after neoadjuvant and adjuvant treatments compared to surgery alone for resectable esophageal carcinoma: a network meta-analysis. Ann Surg. 2017;265:481–91.PubMedCrossRef Pasquali S, Yim G, Vohra RS, et al. Survival after neoadjuvant and adjuvant treatments compared to surgery alone for resectable esophageal carcinoma: a network meta-analysis. Ann Surg. 2017;265:481–91.PubMedCrossRef
41.
Zurück zum Zitat Tan Z, Ma G, Zhao J, et al. Impact of thoracic recurrent laryngeal node dissection: 508 patients with tri-incisional esophagectomy. J Gastrointest Surg. 2014;18:187–93.PubMedCrossRef Tan Z, Ma G, Zhao J, et al. Impact of thoracic recurrent laryngeal node dissection: 508 patients with tri-incisional esophagectomy. J Gastrointest Surg. 2014;18:187–93.PubMedCrossRef
42.
Zurück zum Zitat Taniyama Y, Nakamura T, Mitamura A, et al. A strategy for supraclavicular lymph node dissection using recurrent laryngeal nerve lymph node status in thoracic esophageal squamous cell carcinoma. Ann Thorac Surg. 2013;95:1930–7 Taniyama Y, Nakamura T, Mitamura A, et al. A strategy for supraclavicular lymph node dissection using recurrent laryngeal nerve lymph node status in thoracic esophageal squamous cell carcinoma. Ann Thorac Surg. 2013;95:1930–7
43.
Zurück zum Zitat Yu S, Lin J, Chen C, et al. Recurrent laryngeal nerve lymph node dissection may not be suitable for all early-stage esophageal squamous cell carcinoma patients: an 8-year experience. J Thorac Dis. 2016;8:2803–12.PubMedPubMedCentralCrossRef Yu S, Lin J, Chen C, et al. Recurrent laryngeal nerve lymph node dissection may not be suitable for all early-stage esophageal squamous cell carcinoma patients: an 8-year experience. J Thorac Dis. 2016;8:2803–12.PubMedPubMedCentralCrossRef
44.
Zurück zum Zitat Sahiner B, Pezeshk A, Hadjiiski LM, et al. Deep learning in medical imaging and radiation therapy. Med Phys. 2019;46:e1-36.PubMedCrossRef Sahiner B, Pezeshk A, Hadjiiski LM, et al. Deep learning in medical imaging and radiation therapy. Med Phys. 2019;46:e1-36.PubMedCrossRef
45.
Zurück zum Zitat Li H, Han H, Li Z, et al. High-Resolution Chest X-Ray Bone Suppression Using Unpaired CT Structural Priors. IEEE Trans Med Imaging. 2020;39(10):3053–63. Li H, Han H, Li Z, et al. High-Resolution Chest X-Ray Bone Suppression Using Unpaired CT Structural Priors. IEEE Trans Med Imaging. 2020;39(10):3053–63.
46.
Zurück zum Zitat Liao H, Lin W-A, Zhou SK, Luo J. ADN: artifact disentanglement network for unsupervised metal artifact reduction. IEEE Trans Med Imaging. 2019;39:634–43. PubMedCrossRef Liao H, Lin W-A, Zhou SK, Luo J. ADN: artifact disentanglement network for unsupervised metal artifact reduction. IEEE Trans Med Imaging. 2019;39:634–43. PubMedCrossRef
47.
Zurück zum Zitat Liu M, Chen Y, Fu X, Zhao K, Jiang GL. Proposed revision of CT-based cervical and thoracic lymph node levels for esophageal cancer in UICC 7th version. Radiother Oncol. 2014;113:175–81.PubMedCrossRef Liu M, Chen Y, Fu X, Zhao K, Jiang GL. Proposed revision of CT-based cervical and thoracic lymph node levels for esophageal cancer in UICC 7th version. Radiother Oncol. 2014;113:175–81.PubMedCrossRef
48.
Zurück zum Zitat Kim SJ, Pak K, Chang S. Determination of regional lymph node status using (18)F-FDG PET/CT parameters in oesophageal cancer patients: comparison of SUV, volumetric parameters and intratumoral heterogeneity. Br J Radiol. 2016;89:20150673.PubMedCrossRef Kim SJ, Pak K, Chang S. Determination of regional lymph node status using (18)F-FDG PET/CT parameters in oesophageal cancer patients: comparison of SUV, volumetric parameters and intratumoral heterogeneity. Br J Radiol. 2016;89:20150673.PubMedCrossRef
49.
Zurück zum Zitat Xu M, Wang L, Ouyang M, et al. Prediction of lymph node metastasis by PET/CT metabolic parameters in patients with esophageal squamous cell carcinoma. Nuclear Med Commun. 2019;40:933–9.CrossRef Xu M, Wang L, Ouyang M, et al. Prediction of lymph node metastasis by PET/CT metabolic parameters in patients with esophageal squamous cell carcinoma. Nuclear Med Commun. 2019;40:933–9.CrossRef
50.
Zurück zum Zitat Xu Q, Liu ZK, Cao YK, Li YM, Zhu SC. Relationship of gross tumor volume with lymph node metastasis and prognosis of esophageal carcinoma. Zhonghua Zhong Liu Za Zhi. 2012;34(9):684–87. Xu Q, Liu ZK, Cao YK, Li YM, Zhu SC. Relationship of gross tumor volume with lymph node metastasis and prognosis of esophageal carcinoma. Zhonghua Zhong Liu Za Zhi. 2012;34(9):684–87.
Metadaten
Titel
Prediction of Individual Lymph Node Metastatic Status in Esophageal Squamous Cell Carcinoma Using Routine Computed Tomography Imaging: Comparison of Size-Based Measurements and Radiomics-Based Models
verfasst von
Chenyi Xie, MD, PhD
Yihuai Hu, MD, PhD
Lujun Han, MD, PhD
Jianhua Fu, MD, PhD
Varut Vardhanabhuti, FRCR, PhD
Hong Yang, MD, PhD
Publikationsdatum
26.08.2022
Verlag
Springer International Publishing
Erschienen in
Annals of Surgical Oncology / Ausgabe 13/2022
Print ISSN: 1068-9265
Elektronische ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-022-12207-7

Weitere Artikel der Ausgabe 13/2022

Annals of Surgical Oncology 13/2022 Zur Ausgabe

Wie erfolgreich ist eine Re-Ablation nach Rezidiv?

23.04.2024 Ablationstherapie Nachrichten

Nach der Katheterablation von Vorhofflimmern kommt es bei etwa einem Drittel der Patienten zu Rezidiven, meist binnen eines Jahres. Wie sich spätere Rückfälle auf die Erfolgschancen einer erneuten Ablation auswirken, haben Schweizer Kardiologen erforscht.

Hinter dieser Appendizitis steckte ein Erreger

23.04.2024 Appendizitis Nachrichten

Schmerzen im Unterbauch, aber sonst nicht viel, was auf eine Appendizitis hindeutete: Ein junger Mann hatte Glück, dass trotzdem eine Laparoskopie mit Appendektomie durchgeführt und der Wurmfortsatz histologisch untersucht wurde.

Mehr Schaden als Nutzen durch präoperatives Aussetzen von GLP-1-Agonisten?

23.04.2024 Operationsvorbereitung Nachrichten

Derzeit wird empfohlen, eine Therapie mit GLP-1-Rezeptoragonisten präoperativ zu unterbrechen. Eine neue Studie nährt jedoch Zweifel an der Notwendigkeit der Maßnahme.

Ureterstriktur: Innovative OP-Technik bewährt sich

19.04.2024 EAU 2024 Kongressbericht

Die Ureterstriktur ist eine relativ seltene Komplikation, trotzdem bedarf sie einer differenzierten Versorgung. In komplexen Fällen wird dies durch die roboterassistierte OP-Technik gewährleistet. Erste Resultate ermutigen.

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.